<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndrome</z:e> is a disease known to cause <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> with a structurally <z:mpath ids='MPATH_458'>normal</z:mpath> heart and is linked to SCN5A gene mutation </plain></SENT>
<SENT sid="1" pm="."><plain>However, the mechanism by which <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> develops in cases of Brugada-type electrocardiogram without SCN5A mutation has remained unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, <z:mp ids='MP_0003674'>oxidative stress</z:mp> has been implicated in the pathophysiology of <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We also investigated <z:mp ids='MP_0003674'>oxidative stress</z:mp> levels in the myocardia of patients with Brugada-type electrocardiogram </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Endomyocardial biopsy samples were obtained from 68 patients with Brugada-type electrocardiogram (66 males and two females) </plain></SENT>
<SENT sid="5" pm="."><plain>We performed histological and immunohistochemical analyses for CD45, CD68, and <z:chebi fb="0" ids="32585">4-hydroxy-2-nonenal</z:chebi>-modified protein, which is a major <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation product </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: SCN5A mutation was detected in 14 patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001663'>Ventricular fibrillation</z:hpo> was documented in three patients with SCN5A mutation and in 11 without SCN5A mutation </plain></SENT>
<SENT sid="8" pm="."><plain>In patients with SCN5A mutation, <z:chebi fb="0" ids="32585">4-hydroxy-2-nonenal</z:chebi>-modified protein-positive area was not significantly different between the documented <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) group (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>+ group) and the group without documented <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>- group) </plain></SENT>
<SENT sid="9" pm="."><plain>However, in patients without SCN5A, the area was significantly larger in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>+ group than that in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>- group (P&lt;.05) </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other parameters (<z:mp ids='MP_0003045'>fibrosis</z:mp> area, CD45, and CD68) were not different between the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>+ and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>- group in both SCN5A+ and SCN5A- patients </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:mp ids='MP_0003674'>Oxidative stress</z:mp> is elevated in the myocardium of patients with Brugada-type electrocardiogram who have <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> episodes and do not have SCN5A gene mutations </plain></SENT>
<SENT sid="12" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> may be associated with the occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in patients with Brugada-type electrocardiogram without SCN5A mutation </plain></SENT>
</text></document>